S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

08/02/2024

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

03/15/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Ramkumar Mandalam

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

CryoPort (NASDAQ:CYRX)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more CryoPort Charts.

CryoPort (NASDAQ:CYRX)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more CryoPort Charts.

CryoPort Inc News

Form S-8 - Securities to be offered to employees in employee benefit plans
Saturday 8 March 2025 (4 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 5 March 2025 (7 days ago) • Edgar (US Regulatory)

Cryoport Reports Fourth Quarter and Full Year 2024 Financial Results
Wednesday 5 March 2025 (7 days ago) • PR Newswire (US)

Cryoport to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
Wednesday 19 February 2025 (3 weeks ago) • PR Newswire (US)

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 14 February 2025 (4 weeks ago) • Edgar (US Regulatory)

Cryoport Unveils State-of-the-Art Cryogenic Shipping System for Transporting Lifesaving Biologics and Temperature-Sensitive Therapies
Wednesday 22 January 2025 (2 months ago) • PR Newswire (US)

Moffitt Cancer Center and Cryoport Announce Strategic Collaboration
Wednesday 15 January 2025 (2 months ago) • PR Newswire (US)

Cryoport's MVE Biological Solutions Registers All Manufacturing Facilities with the U.S. Food and Drug Administration ("FDA")
Tuesday 7 January 2025 (2 months ago) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 14 December 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 5 December 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 3 December 2024 (3 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 3 December 2024 (3 months ago) • Edgar (US Regulatory)

More CryoPort Inc News Articles

Brandes Emerging Markets...

Cleveland Cliffs

MaxRets Ventures

Merit Medical Systems

Richtech Robotics

Petroleos Mexicanos PEMEX

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions